Rchr
J-GLOBAL ID:200901066616690204   Update date: Sep. 30, 2022

Suganuma Masami

スガヌマ マサミ | Suganuma Masami
Research field  (1): Pathobiochemistry
Research keywords  (4): がんの化学予防 ,  発がんプロモーション ,  Cancer chemoprevention ,  Tumor promotion
Research theme for competitive and other funds  (9):
  • 2017 - 2019 細胞膜硬化作用による受容体の機能阻害と肺がん治療
  • 2016 - 2019 代表:菅沼雅美)がん転移のメカノバイオロジー:機構と抑制
  • 2009 - 原子間力顕微鏡を用いたがんの診断・予防の研究
  • 2000 - ピロリ菌のTNF-alpha誘導タンパク質(Tipalpha)の胃発がん機構
  • 2000 - Mechanisms of TNF-alpha inducing protein (Tipalpha) released from H. pylori in development of human stomach cancer
Show all
Papers (9):
  • SUGANUMA Masami. Cancer prevention with green tea and its principal constituent, EGCG: from early investigations to current focus on human cancer stem cells. Mol. Cells. 2018. 41. 2. 73-82
  • SUGANUMA Masami. Inhibition of TNF-α-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2/TIS21 via downregulating cytoplasmic nucleolin expression. Exp. Mol. Med. 2018. 50. e449
  • SUGANUMA Masami. Therapeutic impact of (-)-epigallocatechin gallate on human cancer stem cells. 2018. 109. 269-269
  • SUGANUMA Masami. Green tea catechin is an alternative immune checkpoint inhibitor that inhibits PD-L1 expression and lung tumor growth. Molecules. 2018. 23. 8. 2071-2071
  • Hirota Fujiki, Eisaburo Sueoka, Anchalee Rawangkan, Masami Suganuma. Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2017. 143. 12. 2401-2412
more...
Lectures and oral presentations  (3):
  • Biophysical characteristics and anticancer immunity of green tea catechins and their effects of cancer prevention and treatment
    (The First International Confference on Innovation of Functional Foods in ASIA (IFFA2018) 2018)
  • Innovative strategy for cancer treatment, and inhibition of metastasis with (-)-epigallocatechin gallate
    (The 13th Korea-Japan Joint Symposium on Cancer and Aging Research 2016)
  • Green tea as cancer preventive beverage: From development to its biochemical and nanomechanical mechanisms
    (UCLA, Special Lecture: Cancer Cell Mechanics 2015)
Education (3):
  • 1986 - 現在 Tokyo University of Science Faculty of Pharmaceutical Sciences
  • 1975 - 1978 Tokyo University of Science Faculty of Pharmaceutical Sciences Department of Pharmacy
  • - 1978 Tokyo University of Science Faculty of Pharmaceutical Science
Professional career (1):
  • Ph. D. (Tokyo University of Science)
Work history (10):
  • 2014/04 - 現在 埼玉大学理工学研究科戦略的研究部門 教授
  • 2012/10 - 2014/03 Saitama University
  • 2012/04 - 2014/03 : 埼玉県立がんセンター研究所 主席主幹
  • 1993/10 - 2012/03 : 埼玉県立がんセンター研究所 研究員
  • 2001 - : Researcher : Saitama Cancer Center
Show all
Committee career (1):
  • - 現在 日本がん学会学術総会 評議員
Awards (3):
  • 日本ヘリコバクター学会 優秀賞
  • 日本癌学会奨励賞
  • Incitement Award of the Japanese Cancer Association
Association Membership(s) (12):
日本ヘリコバクター学会 ,  日本分子生物学会 ,  日本生化学会 ,  日本癌学会 ,  日本環境変異原学会 ,  アメリカ癌学会 ,  The Japanese Society for Helicobacter Research ,  The Japanese Cancer Association ,  The Japanese Biochemical Society ,  Molecular Biology Society of Japan ,  Environmental Mutagen Society of Japan ,  American Association of Cancer Research
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page